SCHEMBL2907259

SCHEMBL2907259

CCOC(=O)c1cnc2cc(OC)c(N3CCOCC3)cc2c1Nc1cccc(Cl)c1Cl

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.65
SCN5A Q14524 1/20 0.65
CSF1R P07333 8/20 0.62
MAPT P10636 7/20 0.56
GAA P10253 6/20 0.56
LMNA P02545 2/20 0.53
MC4R P32245 2/20 0.53
HTT P42858 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
TDP1 Q9NUW8 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
PTK2B Q14289 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
TP53 P04637 1/20 0.53
EGFR P00533 1/20 0.53
THRB P10828 1/20 0.53
MAPK1 P28482 1/20 0.53
CLK1 P49759 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2911186 0.95 KCNH2 (0.71) KCNH2SCN5ACSF1RMAPTGAA
SCHEMBL2907631 0.91 KCNH2 (0.75) KCNH2SCN5ACSF1RMAPTGAA
SCHEMBL2904510 0.91 KCNH2 (0.65) KCNH2SCN5ACSF1RMAPTGAA
SCHEMBL2914058 0.89 KCNH2 (0.63) KCNH2SCN5ACSF1RMAPTGAA
SCHEMBL2911828 0.89 CSF1R (0.78) KCNH2SCN5ACSF1RCYP3A4CYP2C9
SCHEMBL2911776 0.89 KCNH2 (0.71) KCNH2SCN5ACSF1RMAPTGAA
SCHEMBL2912594 0.88 CSF1R (0.79) KCNH2SCN5ACSF1RMAPTGAA
SCHEMBL2904857 0.88 KCNH2 (0.61) KCNH2SCN5ACSF1RMAPTGAA
SCHEMBL2908314 0.88 CSF1R (0.69) KCNH2SCN5ACSF1RMAPTGAA
SCHEMBL2910808 0.88 KCNH2 (0.60) KCNH2SCN5ACSF1RMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2010496-B1 4-ANILINOQUINOLINE-3-CARBOXAMIDES AS CSF-1R KINASE INHIBITORS ASTRAZENECA AB (SE) 2010-08-25 EP disclosed